TLSA
USDTiziana Life Sciences Ltd. Common Shares
$1.790-0.060 (-3.243%)
Real-time Price
Healthcare
Biotechnology
United Kingdom
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$1.850
High
$1.850
Low
$1.790
Volume
0.16M
Company Fundamentals
Market Cap
212.7M
Industry
Biotechnology
Country
United Kingdom
Trading Stats
Avg Volume
0.38M
Exchange
NCM
Currency
USD
52-Week Range
Low $0.63Current $1.790High $2.6
Related News
GlobeNewswire
Aquestive Therapeutics Announces Leadership Expansion to Support Growth
Changes strategically aligned to support planned launch of Anaphylm™ (dibutepinephrine) Sublingual Film, if approved by the FDA, and to accelerate the Company's ongoing development initiatives Matthew Davis, M.D.,
View more
GlobeNewswire
Tiziana Life Sciences to Present at BIO-Europe in Vienna, Highlighting Innovative Immunomodulation Therapy
BOSTON, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (NASDAQ:TLSA) ("Tiziana" or the "Company"), a biotechnology company developing breakthrough immunomodulation therapies with its lead development
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.